This research is being done because there is a need to improve cancer risk communication and decision-making among adolescents and young adults. In this study, the investigators are looking at whether using a chatbot and online portal for cancer risk information helps improve communication and decision-making. * Over 70,000 adolescents and young adults (AYAs) are diagnosed with cancer in the U.S. every year and up to 10% have genetic changes (or, mutations) that put them at a higher risk of developing new cancers during their lifetimes. These genetic mutations can result in cancer risk syndromes (such as, Lynch Syndrome or Li-Fraumeni Syndrome). Identifying cancer risk syndromes can allow for screening and early diagnosis of future cancers, which could ultimately save lives and offer more care choices for patients. As a result, genetic counseling and testing for cancer risk syndromes is being recommended more for Adolescents and Young Adults with new cancer diagnoses, regardless of family history. * This research study to develop an intervention called AYA-RISE that aims to assist AYAs with cancer risk communication and decision-making around their caregivers.
Age range
12 Years – 24 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of Consenting AYA use AYA-RISE
Timeframe: 2 years
Percentage of Acceptability
Timeframe: 2 years
Change in patient knowledge of cancer risk and screening
Timeframe: baseline to post-visit surveys up to 24 months
Change in psychological distress
Timeframe: baseline to post-visit surveys up to 24 months
Patient ownership of information in the intervention arm
Timeframe: 24 Months
Participants who followed up for recommended care
Timeframe: screening and follow-up over the next year up to 24 Months
Utilization of AYA-RISE
Timeframe: 2 Years
Acceptability of AYA-RISE
Timeframe: 2 Years
Adoption of AYA-RISE
Timeframe: 2 Years
Practicality of Using AYA-RISE
Timeframe: 2 Years
Fidelity of AYA-RISE
Timeframe: 2 Years
Sustainability of AYA-Rise
Timeframe: 2 Years